Wolfgang Link
individual
About
Wolfgang Link is a biomedical researcher focused on FOXO biology, cancer drug resistance, and translational drug discovery. He is a CSIC researcher at the Sols-Morreale Biomedical Research Institute, group leader at the Algarve Biomedical Center Research Institute, and invited assistant professor at the University of Algarve. He is also the scientific co-founder and advisor of Refoxy Pharmaceuticals, a longevity-focused biotech developing FOXO3 therapeutics for age-related diseases.
Areas of interest
longevitybiotechdrug discoveryFOXO3 biologycancer biologyanti-aging therapeuticsfibrosistranslational medicine